178 related articles for article (PubMed ID: 20304183)
1. Prevalence of posttransplantation lymphoproliferative disease in pediatric liver transplant recipients.
Wiederkehr JC; Coelho IM; Avilla SG; e Silva EM; Schuller S; Ouno DD; Wiederkehr BA; Polimeni M
Transplant Proc; 2010 Mar; 42(2):521-2. PubMed ID: 20304183
[TBL] [Abstract][Full Text] [Related]
2. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
Pinho-Apezzato ML; Tannuri U; Tannuri AC; Mello ES; Lima F; Gibelli NE; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Andrade WC; Miyatani HT
Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
[TBL] [Abstract][Full Text] [Related]
3. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
4. Posttransplantation lymphoproliferative disorder in pediatric liver transplantation.
Heo JS; Park JW; Lee KW; Lee SK; Joh JW; Kim SJ; Lee HH; Lee DS; Choi SH; Seo JM; Choe YH
Transplant Proc; 2004 Oct; 36(8):2307-8. PubMed ID: 15561231
[TBL] [Abstract][Full Text] [Related]
5. Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
Roque J; Rios G; Humeres R; Volpi C; Herrera JM; Schultz M; Rios H; Rius M; Salgado C; Hepp J
Transplant Proc; 2006 Apr; 38(3):930-1. PubMed ID: 16647513
[TBL] [Abstract][Full Text] [Related]
6. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
Younes BS; McDiarmid SV; Martin MG; Vargas JH; Goss JA; Busuttil RW; Ament ME
Transplantation; 2000 Jul; 70(1):94-9. PubMed ID: 10919581
[TBL] [Abstract][Full Text] [Related]
7. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
Wu JF; Ho MC; Ni YH; Chen HL; Lu CY; Hsu HY; Lee PH; Chang MH
Transplantation; 2009 Mar; 87(5):758-62. PubMed ID: 19295323
[TBL] [Abstract][Full Text] [Related]
8. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
Koch DG; Christiansen L; Lazarchick J; Stuart R; Willner IR; Reuben A
Liver Transpl; 2007 Jun; 13(6):904-12. PubMed ID: 17539010
[TBL] [Abstract][Full Text] [Related]
9. Posttransplant lymphoproliferative disorder in pediatric liver transplantation.
Uribe M; Hunter B; Alba A; Calabrán L; Flores L; Soto P; Herzog C
Transplant Proc; 2009; 41(6):2679-81. PubMed ID: 19716000
[TBL] [Abstract][Full Text] [Related]
10. Posttransplantation growth in pediatric liver recipients.
Renz JF; de Roos M; Rosenthal P; Mudge C; Bacchetti P; Watson J; Roberts JP; Ascher NL; Emond JC
Liver Transpl; 2001 Dec; 7(12):1040-55. PubMed ID: 11753906
[TBL] [Abstract][Full Text] [Related]
11. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
Mendoza F; Kunitake H; Laks H; Odim J
Pediatr Transplant; 2006 Feb; 10(1):60-6. PubMed ID: 16499589
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for children: Red Cross Children's Hospital experience.
Spearman CW; McCulloch M; Millar AJ; Burger H; Numanoglu A; Goddard E; Cooke L; Cywes S; Rode H; Kahn D
Transplant Proc; 2005 Mar; 37(2):1134-7. PubMed ID: 15848647
[TBL] [Abstract][Full Text] [Related]
13. Development of lymphoproliferative disease after liver transplantation.
Marqués E; Jiménez C; Manrique A; Vallejo GH; Clemares M; Ortega P; Moreno E
Transplant Proc; 2008 Nov; 40(9):2988-9. PubMed ID: 19010169
[TBL] [Abstract][Full Text] [Related]
14. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
Guthery SL; Heubi JE; Bucuvalas JC; Gross TG; Ryckman FC; Alonso MH; Balistreri WF; Hornung RW
Transplantation; 2003 Apr; 75(7):987-93. PubMed ID: 12698085
[TBL] [Abstract][Full Text] [Related]
15. Posttransplant lymphoproliferative disorders in transplant recipients.
Timurağaoğlu A; Uğur-Bilgin A; Colak D; Tuncer M; Gölbaşi I; Hazar V; Kiliçarsłan B; Undar L; Demirbaş A
Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus in pediatric liver transplantation: a single-center experience.
Gibelli NE; Tannuri U; Pinho-Apezzato ML; Tannuri AC; Maksoud-Filho JG; Andrade WC; Velhote MC; Santos MM; Ayoub AA; Marques da Silva M
Transplant Proc; 2009 Apr; 41(3):901-3. PubMed ID: 19376384
[TBL] [Abstract][Full Text] [Related]
17. [Early diagnosis and comprehensive treatments of post-transplantation lymphoproliferative disorder after pediatric liver transplantation].
Deng Z; Jiang L; Zhou T; Shen C; Chen Q; Xia Q
Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):579-82. PubMed ID: 25224233
[TBL] [Abstract][Full Text] [Related]
18. The changing face of post-transplant lymphoproliferative disease in the era of molecular EBV monitoring.
Kerkar N; Morotti RA; Madan RP; Shneider B; Herold BC; Dugan C; Miloh T; Karabicak I; Strauchen JA; Emre S
Pediatr Transplant; 2010 Jun; 14(4):504-11. PubMed ID: 20070559
[TBL] [Abstract][Full Text] [Related]
19. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
[TBL] [Abstract][Full Text] [Related]
20. Outcome of pediatric liver transplant recipients in Turkey: single center experience.
Aydogdu S; Arikan C; Kilic M; Ozgenc F; Akman S; Unal F; Yagci RV; Tokat Y
Pediatr Transplant; 2005 Dec; 9(6):723-8. PubMed ID: 16269042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
